Study Design and Rationale for the Phase 3 Clinical Development Program of Enobosarm, a Selective Androgen Receptor Modulator, for the Prevention and Treatment of Muscle Wasting in Cancer Patients (POW…

Overview of attention for article published in Current Oncology Reports, May 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#30 of 969)
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

So far, Altmetric has seen 1 blog post.

Bodybuilders are turning to a popular new pill to get bigger and stronger, but the chemicals are still undergoing testing and…